Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells
Anticancer Research · 2023
DOI: 10.21873/anticanres.16353 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Chung-I Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.
- Division of General Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.
- Division of General Surgery, Department of Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.
- Bariatric and Metabolic International Surgery Center, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.
- School of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung, Taiwan, R.O.C.
- Division of Hematology-Oncology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.
Zitieren
APA
Huang, C. I., Huang, Y. K., Lee, H. M., Chen, J. H., Su, Y. C., & Lin, P. M. (2023). Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.16353
Vancouver
Huang CI, Huang YK, Lee HM, Chen JH, Su YC, Lin PM. Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells. Anticancer Research. 2023. doi:10.21873/anticanres.16353
BibTeX
@article{Huang2023,
author = {Huang, Chung-I and Huang, Yi-Kai and Lee, Hui-Ming and Chen, Jian-Han and Su, Yu-Chieh and Lin, Pai-Mei},
title = {Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16353}
}
EUVIMED